| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Feb 2, 2026Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and...
Dec 2, 2025Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated with the Instinct sensor, made by Abbott...
Sep 2, 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system...
-
Jul 21, 2025
Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by...
Jun 12, 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the...
-
Apr 24, 2025
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an...
Apr 18, 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync™ sensor for use with the...
Oct 4, 2024Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland,...
-
Aug 7, 2024
Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...
-
Jun 21, 2024
With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as...
Jan 8, 2024With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1 DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc...
-
Jun 23, 2023
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system. These latest data sets,...
-
May 25, 2023
Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support DUBLIN and SEONGNAM, South Korea, May 25, 2023 /
-
Apr 25, 2023
Resolution follows the recent FDA approval of the MiniMed™ 780G system featuring the world's first and only automated insulin delivery system with real-time meal detection technology* DUBLIN,...
-
Apr 21, 2023
Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps DUBLIN, April 21, 2023 /PRNewswire/...
-
Feb 24, 2023
A second randomized controlled trial sponsored by JDRF also demonstrates superiority of automated insulin pump as first-in-line therapy for children with type 1 diabetes DUBLIN and BERLIN, Feb....
Sep 1, 2022First-of-its-kind study demonstrates individuals using the Medtronic system achieved 1.4% absolute reduction in A1c and 27.6% absolute increase in Time in Range DUBLIN, Sept. 1, 2022 /PRNewswire/...
-
Oct 19, 2021
Harder to manage pediatric and adolescent patients achieve 74% Time in Range, and 82% overnight Time in Range, well surpassing clinical consensus guidelines for glycemic control DUBLIN, Oct. 19,...
-
Jun 23, 2021Data Showcases the Company's Most Advanced Product Portfolio Designed to Meet Patients Where They Are In Their Diabetes Journey
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 81th scientific sessions virtual meeting, June...
-
Jun 2, 2021
Results Demonstrate 76% Time in Range and 94% Time in Advanced Hybrid Closed Loop Mode DUBLIN, June 2, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today...
-
Jun 1, 2021
Data on the Company's Holistic Portfolio Will Include Real-World Data on MiniMed™ 780G System and New Data on Medtronic Continuous Glucose Monitoring Systems and Extended-Wear Infusion Set...
-
May 26, 2021
New No Fingerstick1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System DUBLIN, May 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical...
-
Jun 12, 2020Data from Two Key Clinical Trials of the Next-Generation Medtronic Automated Insulin Pump Demonstrates Positive Results for Patients with Type 1 Diabetes
DUBLIN, June 12, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today presented results from its U.S. pivotal trial of its investigational MiniMed™...
-
Jun 12, 2020Investment with Blackstone Life Sciences Expected to Accelerate Medtronic Diabetes Pump and CGM Technology Pipeline
DUBLIN and NEW YORK, June 12, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) and Blackstone (NYSE:BX) today announced that Medtronic intends to significantly increase research and development...
-
Jun 11, 2020Next Generation Closed Loop Insulin Pump System Features
DUBLIN, June 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Marking of its MiniMed™ 780G system, a...
-
Jun 8, 2019
DUBLIN - June 8, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the enrollment of the first study participants in the company's pivotal trial of its...